{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:12:26Z","timestamp":1791335546347,"version":"4.3.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,3,11]],"date-time":"2011-03-11T00:00:00Z","timestamp":1299801600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1007\/s10549-011-1433-2","type":"journal-article","created":{"date-parts":[[2011,3,10]],"date-time":"2011-03-10T13:14:14Z","timestamp":1299762854000},"page":"185-190","source":"Crossref","is-referenced-by-count":90,"title":["Relative contributions of BRCA1 and BRCA2 mutations to \u201ctriple-negative\u201d breast cancer in Ashkenazi Women"],"prefix":"10.1007","volume":"129","author":[{"given":"E.","family":"Comen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Davids","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Kirchhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Hudis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Offit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Robson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,3,11]]},"reference":[{"issue":"16","key":"1433_CR1","doi-asserted-by":"crossref","first-page":"9212","DOI":"10.1073\/pnas.96.16.9212","volume":"96","author":"CM Perou","year":"1999","unstructured":"Perou CM, Jeffrey SS, van de Rijn M, Rees CA, Eisen MB, Ross DT, Pergamenschikov A, Williams CF, Zhu SX, Lee JC, Lashkari D, Shalon D, Brown PO, Botstein D (1999) Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc Natl Acad Sci USA 96(16):9212\u20139217","journal-title":"Proc Natl Acad Sci USA"},{"issue":"15","key":"1433_CR2","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1200\/JCO.2007.13.1748","volume":"26","author":"EA Rakha","year":"2008","unstructured":"Rakha EA, Reis-Filho JS, Ellis IO (2008) Basal-like breast cancer: a critical review. J Clin Oncol 26(15):2568\u20132581. doi: 10.1200\/JCO.2007.13.1748","journal-title":"J Clin Oncol"},{"issue":"43","key":"1433_CR3","doi-asserted-by":"crossref","first-page":"5846","DOI":"10.1038\/sj.onc.1209876","volume":"25","author":"NC Turner","year":"2006","unstructured":"Turner NC, Reis-Filho JS (2006) Basal-like breast cancer and the BRCA1 phenotype. Oncogene 25(43):5846\u20135853. doi: 10.1038\/sj.onc.1209876","journal-title":"Oncogene"},{"issue":"10","key":"1433_CR4","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/nrc1457","volume":"4","author":"N Turner","year":"2004","unstructured":"Turner N, Tutt A, Ashworth A (2004) Hallmarks of \u2018BRCAness\u2019 in sporadic cancers. Nat Rev Cancer 4(10):814\u2013819. doi: 10.1038\/nrc1457","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"1433_CR5","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1136\/jmg.2009.067850","volume":"46","author":"DG Evans","year":"2009","unstructured":"Evans DG, Lalloo F, Cramer A, Jones EA, Knox F, Amir E, Howell A (2009) Addition of pathology and biomarker information significantly improves the performance of the Manchester scoring system for BRCA1 and BRCA2 testing. J Med Genet 46(12):811\u2013817. doi: 10.1136\/jmg.2009.067850","journal-title":"J Med Genet"},{"issue":"20","key":"1433_CR6","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1056\/NEJM199705153362001","volume":"336","author":"JP Struewing","year":"1997","unstructured":"Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, Timmerman MM, Brody LC, Tucker MA (1997) The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336(20):1401\u20131408. doi: 10.1056\/NEJM199705153362001","journal-title":"N Engl J Med"},{"issue":"1","key":"1433_CR7","doi-asserted-by":"crossref","first-page":"R8","DOI":"10.1186\/bcr658","volume":"6","author":"ME Robson","year":"2004","unstructured":"Robson ME, Chappuis PO, Satagopan J, Wong N, Boyd J, Goffin JR, Hudis C, Roberge D, Norton L, Begin LR, Offit K, Foulkes WD (2004) A combined analysis of outcome following breast cancer: differences in survival based on BRCA1\/BRCA2 mutation status and administration of adjuvant treatment. Breast Cancer Res 6(1):R8\u2013R17. doi: 10.1186\/bcr658","journal-title":"Breast Cancer Res"},{"issue":"3","key":"1433_CR8","doi-asserted-by":"crossref","first-page":"176","DOI":"10.2353\/jmoldx.2009.080137","volume":"11","author":"L Zhang","year":"2009","unstructured":"Zhang L, Kirchhoff T, Yee CJ, Offit K (2009) A rapid and reliable test for BRCA1 and BRCA2 founder mutation analysis in paraffin tissue using pyrosequencing. J Mol Diagn 11(3):176\u2013181. doi: 10.2353\/jmoldx.2009.080137","journal-title":"J Mol Diagn"},{"issue":"8","key":"1433_CR9","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E","volume":"17","author":"RG Newcombe","year":"1998","unstructured":"Newcombe RG (1998) Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 17(8):857\u2013872","journal-title":"Stat Med"},{"issue":"158","key":"1433_CR10","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2307\/2276774","volume":"22","author":"EB Wilson","year":"1927","unstructured":"Wilson EB (1927) Probable inference, the law of succession, and statistical inference. J Am Stat Assoc 22(158):209\u2013212","journal-title":"J Am Stat Assoc"},{"issue":"27","key":"1433_CR11","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1200\/JCO.2010.28.0719","volume":"28","author":"JS Kwon","year":"2010","unstructured":"Kwon JS, Gutierrez-Barrera AM, Young D, Sun CC, Daniels MS, Lu KH, Arun B (2010) Expanding the criteria for BRCA mutation testing in breast cancer survivors. J Clin Oncol 28(27):4214\u20134220. doi: 10.1200\/JCO.2010.28.0719","journal-title":"J Clin Oncol"},{"key":"1433_CR12","doi-asserted-by":"crossref","unstructured":"Gonzalez-Angulo AM, Timms KM, Liu S, Chen H, Litton J, Potter J, Lanchbury JS, Stemke-Hale KA, Hennessy B, Arun BK, Hortobagyi GN, Do K-A, Mills GB, Meric-Bernstam F (2011) Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer. Clinical Cancer Research. doi: 10.1158\/1078-0432.ccr-10-2560","DOI":"10.1158\/1078-0432.CCR-10-2560"},{"issue":"19","key":"1433_CR13","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1093\/jnci\/djg050","volume":"95","author":"WD Foulkes","year":"2003","unstructured":"Foulkes WD, Stefansson IM, Chappuis PO, Begin LR, Goffin JR, Wong N, Trudel M, Akslen LA (2003) Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst 95(19):1482\u20131485","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"1433_CR14","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/(SICI)1097-0142(19970801)80:3<435::AID-CNCR11>3.0.CO;2-Y","volume":"80","author":"SE Karp","year":"1997","unstructured":"Karp SE, Tonin PN, B\u00e9gin LR, Martinez JJ, Zhang JC, Pollak MN, Foulkes WD (1997) Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women. Cancer 80(3):435\u2013441","journal-title":"Cancer"},{"issue":"4","key":"1433_CR15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1200\/JOP.777003","volume":"6","author":"ME Hammond","year":"2010","unstructured":"Hammond ME, Hayes DF, Wolff AC, Mangu PB, Temin S (2010) American society of clinical oncology\/college of american pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Oncol Pract 6(4):195\u2013197. doi: 10.1200\/JOP.777003","journal-title":"J Oncol Pract"},{"issue":"26","key":"1433_CR16","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1200\/JCO.2008.16.6231","volume":"26","author":"DP Atchley","year":"2008","unstructured":"Atchley DP, Albarracin CT, Lopez A, Valero V, Amos CI, Gonzalez-Angulo AM, Hortobagyi GN, Arun BK (2008) Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer. J Clin Oncol 26(26):4282\u20134288. doi: 10.1200\/JCO.2008.16.6231","journal-title":"J Clin Oncol"},{"key":"1433_CR17","doi-asserted-by":"crossref","unstructured":"Kandel MJ, Stadler Z, Masciari S et al. (2006) Prevalence of BRCA1 mutations in triple negative breast cancer (BC). J Clin Oncol, 2006 ASCO Annual Meeting Proceedings Part I, vol 24, No. 18S (June 20 Supplement)","DOI":"10.1200\/jco.2006.24.18_suppl.508"},{"issue":"2","key":"1433_CR18","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s10689-008-9216-6","volume":"8","author":"T Distelman-Menachem","year":"2009","unstructured":"Distelman-Menachem T, Shapira T, Laitman Y, Kaufman B, Barak F, Tavtigian S, Friedman E (2009) Analysis of BRCA1\/BRCA2 genes\u2019 contribution to breast cancer susceptibility in high risk Jewish Ashkenazi women. Fam Cancer 8(2):127\u2013133. doi: 10.1007\/s10689-008-9216-6","journal-title":"Fam Cancer"},{"key":"1433_CR19","author":"Y Laitman","year":"2010","unstructured":"Laitman Y, Borsthein RT, Stoppa-Lyonnet D, Dagan E, Castera L, Goislard M, Gershoni-Baruch R, Goldberg H, Kaufman B, Ben-Baruch N, Zidan J, Maray T, Soussan-Gutman L, Friedman E (2010) Germline mutations in BRCA1 and BRCA2 genes in ethnically diverse high risk families in Israel. Breast Cancer Res Treat. doi: 10.1007\/s10549-010-1217-0","journal-title":"Breast Cancer Res Treat"},{"issue":"8","key":"1433_CR20","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/jmg.39.8.611","volume":"39","author":"ND Kauff","year":"2002","unstructured":"Kauff ND, Perez-Segura P, Robson ME, Scheuer L, Siegel B, Schluger A, Rapaport B, Frank TS, Nafa K, Ellis NA, Parmigiani G, Offit K (2002) Incidence of non-founder BRCA1 and BRCA2 mutations in high risk Ashkenazi breast and ovarian cancer families. J Med Genet 39(8):611\u2013614","journal-title":"J Med Genet"},{"issue":"6","key":"1433_CR21","first-page":"1739","volume":"7","author":"J Chang","year":"2001","unstructured":"Chang J, Hilsenbeck SG, Sng JH, Wong J, Ragu GC (2001) Pathological features and BRCA1 mutation screening in premenopausal breast cancer patients. Clin Cancer Res 7(6):1739\u20131742","journal-title":"Clin Cancer Res"},{"issue":"5","key":"1433_CR22","first-page":"1206","volume":"60","author":"R Lidereau","year":"2000","unstructured":"Lidereau R, Eisinger F, Champeme MH, Nogues C, Bieche I, Birnbaum D, Pallud C, Jacquemier J, Sobol H (2000) Major improvement in the efficacy of BRCA1 mutation screening using morphoclinical features of breast cancer. Cancer Res 60(5):1206\u20131210","journal-title":"Cancer Res"},{"issue":"10","key":"1433_CR23","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1093\/annonc\/mdp051","volume":"20","author":"BG Haffty","year":"2009","unstructured":"Haffty BG, Choi DH, Goyal S, Silber A, Ranieri K, Matloff E, Lee MH, Nissenblatt M, Toppmeyer D, Moran MS (2009) Breast cancer in young women (YBC): prevalence of BRCA1\/2 mutations and risk of secondary malignancies across diverse racial groups. Ann Oncol 20(10):1653\u20131659. doi: 10.1093\/annonc\/mdp051","journal-title":"Ann Oncol"},{"key":"1433_CR24","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2407-9-86","volume":"9","author":"SR Young","year":"2009","unstructured":"Young SR, Pilarski RT, Donenberg T, Shapiro C, Hammond LS, Miller J, Brooks KA, Cohen S, Tenenholz B, Desai D, Zandvakili I, Royer R, Li S, Narod SA (2009) The prevalence of BRCA1 mutations among young women with triple-negative breast cancer. BMC Cancer 9:86. doi: 10.1186\/1471-2407-9-86","journal-title":"BMC Cancer"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-011-1433-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-011-1433-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-011-1433-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T07:26:03Z","timestamp":1592378763000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-011-1433-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,11]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["1433"],"URL":"https:\/\/doi.org\/10.1007\/s10549-011-1433-2","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,11]]}}}